首页> 美国卫生研究院文献>OncoTargets and therapy >Fentanyl Inhibits Lung Cancer Viability and Invasion via Upregulation of miR-331-3p and Repression of HDAC5
【2h】

Fentanyl Inhibits Lung Cancer Viability and Invasion via Upregulation of miR-331-3p and Repression of HDAC5

机译:芬太尼抑制肺癌的活力和侵袭通过U-331-3P的上调和HDAC5的抑制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Non-small cell lung cancer (NSCLC) accounts for more than 80% of lung cancer cases and remains the primary cause of cancer-related deaths worldwide. Fentanyl is a commonly utilized anesthetic during the process of tumor resection, and exhibits inhibitory effects on the progression of numerous cancer types, including pancreatic cancer, colorectal cancer and gastric cancer. However, the effects of fentanyl on the cell viability and invasion of NSCLC has not been investigated. Current study aimed to investigate the effects and the mechanisms underlying the effects of fentanyl on NSCLC.
机译:非小细胞肺癌(NSCLC)占肺癌病例的80%以上,仍然是全世界癌症相关死亡的主要原因。芬太尼是肿瘤切除过程中常用的麻醉剂,对大量癌症类型的进展表现出抑制作用,包括胰腺癌,结直肠癌和胃癌。然而,尚未研究芬太尼对细胞活力和侵袭NSCLC的影响。目前的研究旨在探讨芬太尼对NSCLC效果的影响和机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号